Ford Financial Group LLC Sells 99 Shares of UnitedHealth Group Inc (NYSE:UNH)
Ford Financial Group LLC decreased its holdings in UnitedHealth Group Inc (NYSE:UNH) by 11.0% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 800 shares of the healthcare conglomerate’s stock after selling 99 shares during the period. Ford Financial Group LLC’s holdings in UnitedHealth Group were worth $249,000 as of its most recent SEC filing.
Several other institutional investors have also bought and sold shares of UNH. Exchange Traded Concepts LLC increased its holdings in shares of UnitedHealth Group by 140.0% in the 2nd quarter. Exchange Traded Concepts LLC now owns 132 shares of the healthcare conglomerate’s stock worth $39,000 after purchasing an additional 77 shares in the last quarter. Old North State Trust LLC bought a new stake in shares of UnitedHealth Group in the 3rd quarter worth $39,000. Your Advocates Ltd. LLP boosted its stake in shares of UnitedHealth Group by 33.3% in the 2nd quarter. Your Advocates Ltd. LLP now owns 400 shares of the healthcare conglomerate’s stock worth $44,000 after buying an additional 100 shares during the last quarter. Modus Advisors LLC purchased a new position in shares of UnitedHealth Group in the 2nd quarter worth $62,000. Finally, Norway Savings Bank boosted its stake in shares of UnitedHealth Group by 437.5% in the 3rd quarter. Norway Savings Bank now owns 215 shares of the healthcare conglomerate’s stock worth $67,000 after buying an additional 175 shares during the last quarter. 86.39% of the stock is owned by institutional investors and hedge funds.
In other news, EVP Marianne D. Short sold 12,000 shares of UnitedHealth Group stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $321.34, for a total value of $3,856,080.00. Following the sale, the executive vice president now directly owns 140,885 shares of the company’s stock, valued at $45,271,985.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Richard T. Burke sold 10,000 shares of UnitedHealth Group stock in a transaction dated Wednesday, July 22nd. The stock was sold at an average price of $303.50, for a total value of $3,035,000.00. Following the completion of the sale, the director now directly owns 159,215 shares in the company, valued at $48,321,752.50. The disclosure for this sale can be found here. Over the last three months, insiders have sold 47,336 shares of company stock worth $14,928,276. Insiders own 0.80% of the company’s stock.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Monday, October 19th. The healthcare conglomerate reported $3.51 EPS for the quarter, beating the Zacks’ consensus estimate of $2.98 by $0.53. The business had revenue of $65.12 billion for the quarter, compared to analysts’ expectations of $63.97 billion. UnitedHealth Group had a return on equity of 29.28% and a net margin of 6.90%. The business’s quarterly revenue was up 7.9% on a year-over-year basis. During the same period last year, the firm earned $3.88 earnings per share. Sell-side analysts anticipate that UnitedHealth Group Inc will post 16.58 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th were issued a dividend of $1.25 per share. The ex-dividend date was Friday, September 11th. This represents a $5.00 dividend on an annualized basis and a yield of 1.52%. UnitedHealth Group’s dividend payout ratio is presently 33.09%.
UNH has been the topic of a number of research reports. Raymond James raised their price target on UnitedHealth Group from $350.00 to $355.00 and gave the stock a “strong-buy” rating in a research note on Thursday. Bank of America raised their price target on UnitedHealth Group from $351.00 to $365.00 and gave the stock a “buy” rating in a research note on Friday, August 28th. Oppenheimer raised their price target on UnitedHealth Group from $353.00 to $375.00 and gave the stock an “outperform” rating in a research note on Thursday. Piper Sandler raised their price target on UnitedHealth Group from $350.00 to $385.00 and gave the stock an “overweight” rating in a research note on Thursday. Finally, UBS Group raised their price target on UnitedHealth Group from $319.00 to $330.00 and gave the stock a “neutral” rating in a research note on Friday. Four investment analysts have rated the stock with a hold rating, twenty-one have issued a buy rating and one has given a strong buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $346.68.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Further Reading: Understanding Specialty Certificates of Deposit
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.